Document:

Exhibit 10.10

Exhibit 10.10

PROMISSORY NOTE

			
	 	 	 
	$200,000.00
	 	May _____, 2010

FOR VALUE RECEIVED, the undersigned (“Debtors”), hereby jointly and severally promise to pay
to JRT Productions, Inc., a California corporation, or its assigns (“JRT”), the principal amount of
$200,000.00 due to JRT by Debtors pursuant that certain Agreement and Plan of Merger, dated as of
March 17, 2010 (the “Merger Agreement”; the terms defined therein are used herein as therein
defined) and that certain Agreement for the Purchase and Sale of Stock, dated as of March 17, 2010
(the “Stock Exchange Agreement”), on the following terms and conditions:

1. Term. This Note shall be for a term of six (6) months and shall be due and payable,
principal and interest, (a) at the expiration of six (6) months following the Closing Date or (b)
upon occurrence of an event of Default and failure by Debtors to cure such Default pursuant to
Paragraph 5 hereof, whichever is the earliest to occur (the “Due Date”).

2. Interest Rates. The principal amount of this Note shall accrue monthly interest at the
rate of seven percent (7 %) per annum, with such accrued and unpaid interest, if not previously
paid in full to JRT, to be paid to JRT on the Due Date. If Debtors fail to pay the outstanding
principal amount, accrued and unpaid interest or any other amount due under this Note on the Due
Date, Debtors shall pay, in addition to such interest as may otherwise be due, default interest on
each such overdue principal and interest amount, at the rate of ten percent (10%) per annum, which
shall accrue monthly from the Due Date until such time as all unpaid amounts and default interest
are paid in full.

3. Event of Default. The occurrence of any of the following shall constitute an Event of
Default:

a. Failure to Timely Pay. The failure of Debtors to pay JRT the full amount of unpaid
principal and accrued and unpaid interest on the principal on the Due Date.

b. Breach of Representations and Warranties. Breach of representations and warranties
made by any of the Debtors pursuant to the Merger Agreement, the Ancillary Documents or the Stock
Exchange Agreement.

c. Violation of Covenants. Violation or failure to honor any of the covenants,
promises or agreements made by any of the Debtors pursuant to the Merger Agreement, the Ancillary
Documents and the Stock Exchange Agreement.

d. Voluntary Bankruptcy or Insolvency Proceedings. Either of the Debtors (i)
commences a voluntary case or any other proceeding seeking liquidation, reorganization or other
relief with respect to itself or its debts under any bankruptcy, insolvency or similar law or
consents to any appointment of or taking possession of its property by any official in any
involuntary case or other proceeding commenced against it; (ii) applies for or consent to the
appointment of a receiver, trustee, liquidator or custodian of itself or of all or a substantial
part of its property; (iii) is dissolved or liquidated in full or in part; (v) becomes insolvent
(as such term may be defined or interpreted under any applicable statute); or (vi) takes any action for the
purpose of effecting any of the foregoing.

 

 

 

e. Involuntary Bankruptcy or Insolvency Proceedings. (i) A proceeding for the
appointment of a receiver, trustee, liquidator or custodian of either of the Debtors or of both or
substantial part of property of any of the Debtors, or an involuntary proceeding or other
proceedings seeking liquidation, reorganization or other relief with respect to either of the
Debtors or their debts under any bankruptcy or insolvency law is commenced, and (ii) an order for
relief is entered or such proceeding is not dismissed within thirty (30) days of commencement,
whichever earliest.

4. Rights of JRT Upon Default. Upon the occurrence or existence of any Event of Default,
and from the date of a written notice given by JRT to either of the Debtors, which notice shall set
forth the nature of the Event of Default and the necessary actions to be taken by Debtors to cure
such Default (“Notice of Default”), the Debtors shall have ten (10) calendar days to cure such
Default (“Cure Period”). If the Default is not cured prior to the expiration of the Cure Period,
the full amount of principal and accrued and unpaid interest due under this Note, plus any other
amounts, including reasonable attorneys’ fees incurred by JRT in connection with enforcement of
Debtors’ obligations under the Note, shall become due and payable.

5. Prepayment. The Debtors shall have the right, but not the obligation, to prepay this
Note in whole or in part at any time prior to the Due Date. Any such prepayment shall be applied
first, to the outstanding interest accrued and unpaid under the Note, and second, if the amount of
prepayment exceeds the amount of the accrued and unpaid interest, to the payment of the principal
amount owing under the Note.

6. Security Interest. This Note is secured by the JRT Collateral pursuant to the terms of
the Merger Agreement and the JRT Pledge and Security Agreement.

7. Conversion. At any time and from time to time prior to the payment of all obligations
under this Note in full, including the principal, the interest and the default interest, if any,
JRT, in its sole discretion, shall have the right to convert all or any portion of this Note into
fully paid and nonassessable shares of common stock (“Conversion Shares”) of ImaRx Therapeutics,
Inc. (“ImaRx”) in accordance with the terms hereof (“Conversion Rights”):

a. Conversion Procedure. JRT may exercise the Conversion Rights every thirty (30) days
following the Closing Date with respect to all or any portion of the obligations under this Note,
but not less than $20,000 at a time, by sending to ImaRx, by facsimile, overnight or first class
certified mail or email, a written notice of conversion (the “Conversion Notice”) in substantially
the form attached as Exhibit A hereto. The Conversion Notice shall specify the amount to be
converted (the “Conversion Amount”), the Conversion Price (as defined below) and the basis for
calculation thereof (as provided herein), the date on which the Conversion Notice is sent (the
“Conversion Date”), the name or names of person(s) in which the certificate or certificates for
Conversion Shares shall be issued, and the manner in which the certificates shall be delivered. As
promptly as practicable, but in no event later than seven (7) Business Days following the
Conversion Date, ImaRx shall at its expense issue and deliver to JRT a certificate or certificates for the number of Conversion Shares equal to the Conversion Amount
divided by the Conversion Price.

 

 

 

b. Conversion Price. “Conversion Price” shall mean the average of three (3) Trading Prices
(as defined herein) for the Conversion Shares on the three (3) Trading Days immediately preceding
the Conversion Date. “Trading Price” shall mean the intraday trading price on the
Over-the-Counter Bulletin Board (the “OTCBB”) as reported by a reliable reporting service mutually
acceptable to JRT and Debtors, or, if the OTCBB is not the principal trading market for the
Conversion Shares, the intraday trading price of such Conversion Shares on the principal securities
exchange or trading market where such Conversion Shares are listed or traded or, if no intraday
trading price of such Conversion Share is available in any of the foregoing manners, the average of
the intraday trading prices of any market makers for such Conversion Shares that are listed in the
“pink sheets” by the National Quotation Bureau, Inc. If the Trading Price cannot be calculated
for Conversion Shares in the manner provided above, the Trading Price shall be the fair market
value of Conversion Shares as mutually determined by JRT and ImaRx. “Trading Day” shall mean any
day on which the Conversion Shares are traded for any period on the OTCBB, or on the principal
securities exchange or other securities market on which the Conversion Shares are then being
traded.

c. Conversion Shares. All and any Conversion Shares issued to JRT upon the exercise of the
Conversion Rights (i) shall be subject to the terms and conditions of the Registration Rights
Agreement (as defined in the Merger Agreement), and be included in the definition of Registrable
Shares under the Registration Rights Agreement; and (ii) shall be subject to the Put Rights (as
defined in the Stock Exchange Agreement), and shall be included in the definition of the Subject
Shares for purposes of Section 7.6 thereof.

8. Assignment and Transfer. This Note shall be freely assignable and transferrable by JRT,
subject to the prior written notice to the Debtors.

9. No Modification. No modification or waiver of any term of this Note shall be allowed
unless by written agreement signed by the parties hereto. No waiver of any breach or Default
hereunder shall be deemed a waiver of any subsequent breach or Default of the same or similar
nature.

10. Severability. In the event that any provision of this Note or any portion thereof is
deemed unenforceable, all other provisions shall remain in full force and effect.

11. Notices. Any notice required or permitted to be given hereunder shall be governed by
Section 10.3 of the Merger Agreement.

[The remainder of this Page is intentionally left blank.]

 

 

 

Each Debtor, for itself, its successors and assigns, hereby waives diligence, presentment,
protest and demand and notice of protest, demand, dishonor and non-payment of this Note.

THIS NOTE SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF
CALIFORNIA.

	 	 	 	 	 	 	 	 	 	 	 	 	 
	IMARX THERAPEUTICS, INC.,

a Delaware corporation	 	SYCAMORE FILMS, INC.,

a Nevada corporation	 	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	By:

	 	 	 	 	 	By:	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 
	 

	 	Name:
	 	 	 	 	 	Name:	 	 	 	 
	 

	 	Title:
	 	 

	 	 	 	Title:
	 	 

	 	 
	 

	 	 	 	 

	 	 	 	 	 	 

	 	 

 

 

 

Exhibit A

Conversion Notice

This Conversion Notice is given pursuant to the terms of certain Note in the principal amount
of $200,000, issued on April _____, 2010, by ImaRx Therapeutics, Inc., a Delaware corporation, and
Sycamore Films, Inc., a Nevada corporation, in favor of JRT Productions, Inc., a California
corporation.

The undersigned, being the holder of the Note referenced above, hereby elects to convert the
obligations under the Note into the Conversion Shares as defined therein on the following terms and
conditions:

Conversion Date [the date this Conversion Notice is sent]: _______________________ 

Conversion Amount [not less than $20,000]: _______________________ 

Conversion Price: [insert the result under item (iv)]
 _______________________, calculated as the average of three (3) Trading Prices for the Conversion Shares on three (3)
Trading Days preceding the Conversion Date:

(i) First Trading Price _______________________ on  _______________;

(ii) Second Trading Price _______________________ on _______________;

(iii) Third Trading Price _______________________ on _______________;

(iv) the sum of items (i) through (iii): _______________________;

(v) item (iv) divided by three (3): _______________________.

Name(s) and addresses of the person(s) in which names the Conversion Shares shall be
registered or issued:

__________________________________________________________

__________________________________________________________

__________________________________________________________

__________________________________________________________

IN WITNESS WHEREOF, the undersigned have caused this Agreement to be signed as of the date hereof.

	 	 	 	 	 	 	 	 	 
	Name :

	 	 	;
	 	Signature:Exhibit 10.11

Exhibit 10.11

JRT PLEDGE AND SECURITY AGREEMENT

THIS JRT PLEDGE AND SECURITY AGREEMENT (the “Agreement”), dated as of May _____, 2010, is by and
among ImaRx Therapeutics, Inc., a Delaware corporation (the “Debtor”), and JRT Productions, Inc., a
California corporation (the “Secured Party”), in connection with (1) that certain Agreement and
Plan of Merger, dated as of March 17, 2010, (the “Merger Agreement”; the terms defined therein
being used herein as therein defined) among Debtor and Sycamore Films, Inc., a Nevada corporation
(the “Subsidiary”), on the one hand, and Target, Secured Party, Red Cat (collectively, “Sellers”),
Scotti and Takats (collectively, “Shareholders”), on the other hand; and (2) that certain that
certain Agreement for the Purchase and Sale of Stock, dated as of March 17, 2010 (the “Stock
Exchange Agreement”), by and among the Debtor, on the one hand, and the Subsidiary and the Sellers,
on the other hand.

RECITALS

WHEREAS, the parties have entered into the Merger Agreement and the Stock Exchange Agreement;

WHEREAS, as a part of the payment of the Purchase Price for the Target Shares pursuant to the
Merger Agreement, the Debtor and the Subsidiary executed that certain JRT Note in favor of the
Secured Party in the principal amount of $200,000;

WHEREAS, pursuant to the Stock Exchange Agreement, the Debtor became the owner of 100% of the
issued and outstanding shares of common stock of the Subsidiary;

WHEREAS, pursuant to the terms of the Merger Agreement and the JRT Note, the JRT Note
Indebtedness shall be secured by a first priority perfected pledge of 50% of the issued and
outstanding shares of common stock of the Subsidiary owned by the Debtor;

WHEREAS, it is a condition precedent to Sellers’ obligations to perform under the Merger
Agreement and the Stock Exchange Agreement that the Debtor execute and deliver this Agreement; and

WHEREAS, in order to induce Sellers to enter into the Merger Agreement and the Stock Exchange
Agreement and convey the Target Shares to the Subsidiary and then the shares of common stock in
Subsidiary to the Debtor, the Debtor is willing to grant the security interest specified herein.

AGREEMENT

NOW, THEREFORE, in consideration of the promises and of the mutual covenants contained herein,
the parties hereto agree as follows:

1. Grant of Security Interest. The Debtor hereby pledges to the Secured Party and grants
to the Secured Party a security interest in all right, title and interest of the Debtor in and to
those forty-three million (43,000,000) shares of common stock in the Subsidiary owned by the
Secured Party, representing 50% of the total amount of issued and outstanding shares of stock of
the Subsidiary, together with all funds, investments, securities, interest, dividends, instruments,
documents and records related thereto and all other property credited thereto, accepted for credit
thereto or required to be credited thereto, all additions thereto and substitutions thereof, all
security entitlements arising therefrom and any and all products and proceeds of the foregoing to
secure the Obligator’s obligations under the JRT Note (the “JRT Collateral”).

 

 

 

2. Perfection. In order to perfect, protect or more fully evidence the Secured Party’s
first priority perfected security interest in the JRT Collateral:

a. Financing Statements. The Debtor hereby irrevocably authorizes the Secured Party,
at any time and from time to time, to file in any appropriate jurisdiction any UCC financing
statements, amendments thereto and continuations thereof deemed necessary by the Secured Party to
perfect its security interest in the JRT Collateral.

b. Possession. The Debtor shall deliver to the Secured Party or such agent as
designated by Secured Party, the JRT Collateral evidenced by certificated securities together with
irrevocable stock powers endorsed in blank.

3. Representations and Warranties. The Debtor hereby represents and warrants to the
Secured Party:

a. Location. The Debtor is “located” (for purposes of the UCC) in the State of
Delaware, and will not change such state of location without 10 calendar days prior notice to the
Secured Party. If the Debtor’s location is changed, the Debtor hereby authorizes the Secured Party
to file a financing statement for the purpose of maintaining perfection of its security interest in
the JRT Collateral in such new state location of the Debtor.

b. Validity. The Debtor is the sole owner of the JRT Collateral, has the right to
grant the security interest provided for herein to the Secured Party and has granted to the Secured
Party a valid security interest in the JRT Collateral, free of all liens, encumbrances, transfer
restrictions and adverse claims; such that the security interest in the JRT Collateral of the
Secured Party shall be a first priority security interest when perfected in accordance with Section
2 of this Agreement.

c. Pledged Stock. The JRT Collateral represents 50% of the total amount of issued and
outstanding shares of stock of the Subsidiary and all rights arising therefrom and related thereto,
as stated in Section 1 hereof.

d. Compliance with Law. The Debtor’s execution, delivery and performance of this
Agreement, the grant of the security interest in the JRT Collateral and the consummation of the
transactions contemplated hereunder will not, with or without the giving of notice or the lapse of
time, (i) violate any law applicable to the Debtor; (ii) violate any judgment, writ, injunction or
order of any court or governmental body or officer applicable to the Debtor; (iii) violate or
result in the breach of any agreement to which the Debtor is a party or by which any of Debtor’s
properties, including the JRT Collateral, is bound; or (iv) violate any restriction on the transfer
of any of the JRT Collateral.

 

2

 

e. Third Party Consents. No consent, approval or authorization of any third party or
any governmental body or officer is required for the valid and lawful execution and delivery of
this Agreement, the creation and perfection of the Secured Party’s security interest in the JRT
Collateral or the valid and lawful exercise by the Secured Party of remedies available to it under
this Agreement or applicable law or of the voting and other rights granted to it in this Agreement,
except as may be required for the offer or sale of securities under applicable securities laws.

4. Covenants. The Debtor covenants and agrees that so long as this Agreement shall be in
effect:

a. Sale. Without the prior written consent of the Secured Party, the Debtor shall not
sell, gift, pledge, exchange or otherwise dispose of any of the JRT Collateral.

b. Capital Structure. Without the prior written consent of the Secured Party, the
Debtor shall not cause or permit the Subsidiary to make any change in its capital structure or
issue or create any stock or other equity interest (or any non-equity interest that is convertible
into any stock, membership interest, or other equity interest in the Subsidiary).

c. Value of JRT Collateral. The Debtor shall not take or fail to take any action
which would in any manner impair the value of the JRT Collateral.

d. Claims. The Debtor shall give notice to the Secured Party of, and shall defend
against, any suit, action or proceeding against the JRT Collateral or which could adversely affect
the Secured Party’s security interest in the JRT Collateral granted hereunder.

e. Indemnity. The Debtor shall indemnify the Secured Party and its agents against,
and hold them harmless from, any liability, loss, claim, damage and expense (including reasonable
attorneys’ fees) which may arise in connection with the execution, enforcement or performance by
the Secured Party of this Agreement and/or the JRT Note.

5. Remedies Upon Default. If any Event of Default under the JRT Note shall have occurred
and not be cured within the Cure Period (as defined in the JRT Note), then at the end of the Cure
Period:

a. Secured Party’s Rights. The Secured Party may exercise in respect of the JRT
Collateral, in addition to other rights and remedies provided for herein, the Merger Agreement and
other Ancillary Documents, all of the rights and remedies of a secured party on default under the
UCC and also may sell the JRT Collateral or any part thereof at public or private sale, at any of
the Secured Party’s offices or elsewhere, for cash, on credit or for future delivery, and at such
price or prices and upon such other terms as are commercially reasonable. The Debtor agrees that,
to the extent notice of sale shall be required by law, at least a ten (10) Business Days’ notice to
the Debtor of the time and place of any public sale or the time after which any private sale is to
be made shall constitute reasonable notification. Any sale of the JRT Collateral conducted in
conformity with reasonable commercial practices of reputable banks, commercial finance companies,
insurance companies or other financial institutions disposing of property similar to the Collateral
shall be deemed to be commercially reasonable. The Secured Party may, in its own name or in the
name of a designee or nominee, buy all or any part of the JRT Collateral at
any public sale and, if permitted by applicable law, buy all or any part of the JRT Collateral
at any private sale.

 

3

 

b. Agent for Secured Party. Notwithstanding the generality of the foregoing, the
Secured Party shall have the right to instruct any person holding the JRT Collateral as agent for
the Secured Party to release or liquidate all or any portion of the JRT Collateral which is
sufficient to pay the JRT Note Indebtedness and related costs of enforcement in full, and to
transfer the proceeds of the liquidation sale to the Secured Party.

c. Deficiency. In the event that the proceeds of any sale, surrender, collection or
realization of Collateral is insufficient to pay all outstanding JRT Indebtedness, the Debtor shall
be liable for the deficiency, together with interest thereon at the default rate of seven percent
(7%) per annum, or such lesser rate as shall be fixed by applicable law, together with the costs of
collection and the fees and other client charges of any attorneys employed by the Secured Party to
collect such deficiency.

6. Termination. This Agreement shall terminate upon the earliest of (a) the Debtor’s
receipt of notice from the Secured Party expressly stating that the Secured Party no longer claims
any security interest in the JRT Collateral, (b) transfer of the proceeds of the sale of the JRT
Collateral subsequent to the liquidation sale of Collateral and payment of any outstanding
deficiency thereafter pursuant to Paragraph 5.c of this Agreement, or (c) the payment in full of
the JRT Note Indebtedness. Promptly following the payment in full of the JRT Note Indebtedness,
the Secured Party shall give written notice thereof to the Debtor. Upon termination of this
Agreement, the Secured Party shall execute any such instruments that are reasonably requested by
the Debtor to release its security interest in the JRT Collateral.

7. Miscellaneous.

a. Waiver and Amendment. No failure or delay on the part of the Secured Party in
exercising any right, power or remedy hereunder shall operate as a waiver thereof; nor shall any
single or partial exercise of any such right or remedy preclude any other right or remedy. The
rights and remedies of the Secured Party hereunder are cumulative and are not exclusive of any
rights or remedies provided by law or equity or in any other contract between such parties. No
provision of this Agreement may be amended, waived, modified or terminated, except in a writing
duly signed by the Debtor and the Secured Party.

b. Survival. All warranties, representations and obligations contained herein or in
any of the instruments or documents delivered pursuant to this Agreement shall survive the delivery
of any instruments or documents.

c. Entire Agreement. This Agreement, together with the Merger Agreement, the other
Ancillary Agreements and the Stock Exchange Agreement, constitute the entire agreement between the
parties hereto with respect to the subject matter hereof and supersede all other prior agreements
and understandings both written and oral between the parties with respect to the subject matter
hereof.

d. Successors and Assigns. This Agreement shall bind and the benefits hereof shall
inure to the parties hereto and their respective successors and assigns.

 

4

 

e. Notices. Any notice required or permitted to be given hereunder shall be governed
by Section 10.2 of the Merger Agreement.

f. Governing Law. This Agreement shall be construed, interpreted and the rights of
the parties determined in accordance with the Laws of the State of California, as applied to
agreements among California residents entered into and wholly to be performed within the State of
California (without reference to any choice of law rules that would require the application of the
Laws of any other jurisdiction).

g. Descriptive Headings. The descriptive headings herein are inserted for convenience
of reference only and are not intended to be part of or to affect the meaning or interpretation of
this Agreement.

h. No Strict Construction. The parties hereto have participated jointly in the
negotiation and drafting of this Agreement. In the event an ambiguity or question of intent or
interpretation arises, this Agreement shall be construed as if drafted jointly by the parties
hereto, and no presumption or burden of proof shall arise favoring or disfavoring any party by
virtue of the authorship of any of the provisions of this Agreement.

i. Counterparts. This Agreement may be executed by facsimile in one or more
counterparts, each of which shall be deemed to be an original but all of which shall constitute one
and the same agreement.

j. Severability. In the event that any provision of this Agreement, or the application
thereof, becomes or is declared by a court of competent jurisdiction to be illegal, void or
unenforceable, the remainder of this Agreement shall continue in full force and effect and the
application of such provision to other persons or circumstances shall be interpreted so as
reasonably to effect the intent of the parties hereto. The parties hereto further agree to use
their commercially reasonable efforts to replace such void or unenforceable provision of this
Agreement with a valid and enforceable provision that shall achieve, to the extent possible, the
economic, business and other purposes of such void or unenforceable provision.

 

5

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed and delivered
by their respective corporate officers, thereunto duly authorized, as of the date first above
written.

	 	 	 	 	 	 	 	 	 
	 	 	IMARX THERAPEUTICS, INC.,

a Delaware corporation	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	By:	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	 	 	Name:	 	 	 	 
	 

	 	 	 	Title:
	 	 

	 	 
	 

	 	 	 	 	 	 

	 	 
	 	 	SYCAMORE FILMS INC.,

a Nevada corporation	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	By:	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	 	 	Name:	 	 	 	 
	 

	 	 	 	Title:
	 	 

	 	 
	 

	 	 	 	 	 	 

	 	 
	 	 	JRT PRODUCTIONS, INC.,

a California corporation	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	By:	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	 	 	Name:	 	 	 	 
	 

	 	 	 	Title:
	 	 

	 	 
	 

	 	 	 	 	 	 

	 	 

 

6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00174-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00174-of-00352.parquet"}]]